Downregulation of LncRNA DARS-AS1 Inhibits the Tumorigenesis of Cervical Cancer via Inhibition of IGF2BP3
Authors:
Open Access
- 1 February 2021
- journal article
- research article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 14, 1331-1340
Abstract
Background: Evidence has been shown that long noncoding RNAs (lncRNAs) play an important role in the development of cervical cancer. Recently, lncRNA DARS-AS1 was reported to be dysregulated in several cancer types; however, the role of DARS-AS1 in cervical cancer remains unclear. Methods: Flow cytometry and transwell invasion assays were performed to determine the apoptosis and invasion in cervical cancer cells. In addition, RNA pull-down and fluorescence in situ hybridization (FISH) assays were conducted to assess the interaction between DARS-AS1 and IGF2BP3 in cervical cancer cells. Results: Downregulation of DARS-AS1 significantly induced apoptosis and cell cycle arrest in cervical cancer cells. Meanwhile, the invasion ability of cervical cancer cells was inhibited by DARS-AS1 knockdown as well. RNA pull-down and FISH results showed that DARS-AS1 interacted with IGF2BP3. Mechanistically, DARS-AS1 positively regulated IGF2BP3 expression via stabilization of IGF2BP3 mRNA. Rescue assays confirmed that DARS-AS1 regulated the progression of cervical cancer through interacting with IGF2BP3 in vitro. In addition, in vivo experiments revealed that downregulation of DARS-AS1 inhibited tumor growth in SiHa xenograft model. Conclusion: In this study, we found that downregulation of DARS-AS1 could inhibit the growth of cervical cancer cells via inhibition of IGF2BP3, suggesting DARS-AS1 might serve as a potential target for the treatment of cervical cancer.Keywords
This publication has 33 references indexed in Scilit:
- LncRNA‐TCONS_00026907 is involved in the progression and prognosis of cervical cancer through inhibiting miR‐143‐5pCancer Medicine, 2017
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analysesNucleic Acids Research, 2017
- Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysisThe Lancet Global Health, 2016
- Long noncoding RNAs in cancer: mechanisms of action and technological advancementsMolecular Cancer, 2016
- α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15Scientific Reports, 2016
- Cancer statistics in China, 2015CA: A Cancer Journal for Clinicians, 2016
- The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell DifferentiationScience, 2014
- Cervical Cancer ScreeningJournal of the National Comprehensive Cancer Network, 2014
- Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasisNature, 2010
- Against which human papillomavirus types shall we vaccinate and screen? the international perspectiveInternational Journal of Cancer, 2004